Browsing by Author "Cipolle, Robert J."
Now showing 1 - 1 of 1
Results Per Page
Sort Options
Item Interview with Robert J. Cipolle(University of Minnesota, 2012-06-12) Tobbell, Dominique A.; Cipolle, Robert J.Dr. Robert Cipolle begins his interview by briefly discusses his early life and education. He describes his time in the relatively new Pharm.D. at the University of Minnesota, his residency in Twin Cities area hospitals, and how the atmosphere of acceptance of the clinical pharmacy in Minnesota differed from areas. Dr. Cipolle then discusses the following topics regarding the changing culture surrounding pharmacy and pharmaceuticals: his move to University Hospital to support the growth of the clinical pharmacy program there; running the hospital pharmacy at Saint Paul-Ramsey; conflicts within the pharmacy therapeutics committee; equivalence, substitution, and prescriptive power issues in the 1970s, 1980s, and 1990s; the creation of the Peters Institute of Pharmaceutical Care; the practice of medication therapy management (MTM); the development of a billing system for clinical pharmacy; the training of clinical pharmacists as opposed to pharmacists working in dispensaries; and the introduction of the patient package insert. Following this discussion of larger trends, Dr. Cipolle reflects on his time in administration in the College of Pharmacy, including his time as associate dean under Gilbert Banker, changing the curriculum within the College, and his time as interim dean. He then describes the following: the relationship between the College and the Department of Pharmacology in the Medical School; the conversion to an all Pharm.D. program; the creation of the pharmacy program in Duluth; relations between the College and the basic sciences; failed discussions regarding the creation of a two-year pharmacy technician program; poison control and collaborations with the Medical and Nursing Schools; budget issues and long-range planning; funding from pharmaceutical companies; his time chairing the Conflict of Interest Committee; litigation surrounding the sale of Antilymphocyte Globulin (ALG); the creation of Medication Management Systems, Inc. Dr. Cipolle concludes with a reflection on changing demographics within pharmacy, the changing culture of pharmacy, and the naming of Unit F.